Friday, May 8, 2020

Rutgers Launches Trial of Psoriasis Drug to Fight Deadly COVID-19 Complication

Rutgers is launching a trial of an experimental psoriasis drug that may also fight one of the deadliest complications of COVID-19, a condition that causes the immune system to attack the lungs and other organs.nbcNewYork

No comments:

Post a Comment